nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—peripheral nervous system neoplasm—skin cancer	0.617	1	CtDrD
Tretinoin—CYP1A1—Dacarbazine—skin cancer	0.0295	0.148	CbGbCtD
Tretinoin—CYP2C8—Vismodegib—skin cancer	0.0281	0.141	CbGbCtD
Tretinoin—CYP2A6—Fluorouracil—skin cancer	0.0202	0.101	CbGbCtD
Tretinoin—CYP2C9—Vismodegib—skin cancer	0.0196	0.0981	CbGbCtD
Tretinoin—CYP3A4—Temozolomide—skin cancer	0.0164	0.0823	CbGbCtD
Tretinoin—CYP3A4—Imiquimod—skin cancer	0.0164	0.0823	CbGbCtD
Tretinoin—CYP3A4—Vismodegib—skin cancer	0.0114	0.057	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0106	0.0529	CbGbCtD
Tretinoin—CYP3A7—Docetaxel—skin cancer	0.0106	0.0529	CbGbCtD
Tretinoin—CYP2C8—Fluorouracil—skin cancer	0.00998	0.05	CbGbCtD
Tretinoin—CYP3A4—Vemurafenib—skin cancer	0.00901	0.0451	CbGbCtD
Tretinoin—CYP3A5—Docetaxel—skin cancer	0.00793	0.0397	CbGbCtD
Tretinoin—CYP2C9—Fluorouracil—skin cancer	0.00696	0.0348	CbGbCtD
Tretinoin—CYP3A4—Docetaxel—skin cancer	0.00309	0.0155	CbGbCtD
Tretinoin—CRABP2—skin epidermis—skin cancer	0.00264	0.0606	CbGeAlD
Tretinoin—RARRES1—nipple—skin cancer	0.00191	0.0438	CbGeAlD
Tretinoin—GPRC5A—female reproductive system—skin cancer	0.00189	0.0433	CbGeAlD
Tretinoin—CRABP1—nipple—skin cancer	0.00141	0.0324	CbGeAlD
Tretinoin—CRABP1—neck—skin cancer	0.0014	0.0321	CbGeAlD
Tretinoin—CRABP2—nipple—skin cancer	0.00128	0.0293	CbGeAlD
Tretinoin—RARRES1—skin of body—skin cancer	0.00122	0.0281	CbGeAlD
Tretinoin—RARRES1—mammalian vulva—skin cancer	0.00112	0.0256	CbGeAlD
Tretinoin—RXRG—neck—skin cancer	0.00111	0.0254	CbGeAlD
Tretinoin—ALDH1A1—nipple—skin cancer	0.00107	0.0244	CbGeAlD
Tretinoin—ALDH1A1—neck—skin cancer	0.00105	0.0242	CbGeAlD
Tretinoin—CRABP1—connective tissue—skin cancer	0.001	0.023	CbGeAlD
Tretinoin—RARRES1—female reproductive system—skin cancer	0.000956	0.0219	CbGeAlD
Tretinoin—ALDH1A1—Dopaminergic Neurogenesis—GLI2—skin cancer	0.000943	0.0961	CbGpPWpGaD
Tretinoin—RARG—nipple—skin cancer	0.000933	0.0214	CbGeAlD
Tretinoin—CRABP2—connective tissue—skin cancer	0.000907	0.0208	CbGeAlD
Tretinoin—CRABP1—skin of body—skin cancer	0.000906	0.0208	CbGeAlD
Tretinoin—ALDH1A1—Dopaminergic Neurogenesis—GLI1—skin cancer	0.000887	0.0904	CbGpPWpGaD
Tretinoin—CRABP1—mammalian vulva—skin cancer	0.000826	0.0189	CbGeAlD
Tretinoin—NR0B1—female reproductive system—skin cancer	0.000823	0.0189	CbGeAlD
Tretinoin—CRABP2—skin of body—skin cancer	0.000819	0.0188	CbGeAlD
Tretinoin—ALDH1A1—connective tissue—skin cancer	0.000756	0.0173	CbGeAlD
Tretinoin—CRABP2—mammalian vulva—skin cancer	0.000747	0.0171	CbGeAlD
Tretinoin—ALDH1A2—female reproductive system—skin cancer	0.000733	0.0168	CbGeAlD
Tretinoin—CRABP1—female reproductive system—skin cancer	0.000707	0.0162	CbGeAlD
Tretinoin—ALDH1A1—skin of body—skin cancer	0.000682	0.0157	CbGeAlD
Tretinoin—CYP1A1—skin epidermis—skin cancer	0.000663	0.0152	CbGeAlD
Tretinoin—ALDH1A1—Dopaminergic Neurogenesis—SHH—skin cancer	0.000641	0.0653	CbGpPWpGaD
Tretinoin—CRABP2—female reproductive system—skin cancer	0.00064	0.0147	CbGeAlD
Tretinoin—RXRA—female reproductive system—skin cancer	0.000637	0.0146	CbGeAlD
Tretinoin—ALDH1A1—mammalian vulva—skin cancer	0.000622	0.0143	CbGeAlD
Tretinoin—ALDH1A2—head—skin cancer	0.000613	0.014	CbGeAlD
Tretinoin—RARG—skin of body—skin cancer	0.000598	0.0137	CbGeAlD
Tretinoin—CRABP1—head—skin cancer	0.000591	0.0136	CbGeAlD
Tretinoin—RARB—female reproductive system—skin cancer	0.000572	0.0131	CbGeAlD
Tretinoin—RARRES1—lymph node—skin cancer	0.000559	0.0128	CbGeAlD
Tretinoin—ALDH1A1—lymphoid tissue—skin cancer	0.000553	0.0127	CbGeAlD
Tretinoin—CYP2C18—mammalian vulva—skin cancer	0.000547	0.0125	CbGeAlD
Tretinoin—RARG—mammalian vulva—skin cancer	0.000545	0.0125	CbGeAlD
Tretinoin—CRABP2—head—skin cancer	0.000534	0.0123	CbGeAlD
Tretinoin—ALDH1A1—female reproductive system—skin cancer	0.000533	0.0122	CbGeAlD
Tretinoin—RXRA—head—skin cancer	0.000532	0.0122	CbGeAlD
Tretinoin—RARB—head—skin cancer	0.000478	0.011	CbGeAlD
Tretinoin—RXRG—head—skin cancer	0.000467	0.0107	CbGeAlD
Tretinoin—RARG—female reproductive system—skin cancer	0.000467	0.0107	CbGeAlD
Tretinoin—RARA—lymphoid tissue—skin cancer	0.000455	0.0104	CbGeAlD
Tretinoin—ALDH1A1—head—skin cancer	0.000445	0.0102	CbGeAlD
Tretinoin—RXRB—head—skin cancer	0.000439	0.0101	CbGeAlD
Tretinoin—RARA—female reproductive system—skin cancer	0.000439	0.0101	CbGeAlD
Tretinoin—ALDH1A2—lymph node—skin cancer	0.000429	0.00984	CbGeAlD
Tretinoin—RARG—head—skin cancer	0.00039	0.00894	CbGeAlD
Tretinoin—RXRG—Adipogenesis—ASIP—skin cancer	0.000369	0.0376	CbGpPWpGaD
Tretinoin—RARA—head—skin cancer	0.000367	0.00841	CbGeAlD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000351	0.0358	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—ASIP—skin cancer	0.000347	0.0354	CbGpPWpGaD
Tretinoin—RARB—lymph node—skin cancer	0.000335	0.00768	CbGeAlD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.000333	0.0339	CbGpPWpGaD
Tretinoin—CYP1A1—nipple—skin cancer	0.000321	0.00736	CbGeAlD
Tretinoin—ALDH1A1—lymph node—skin cancer	0.000312	0.00715	CbGeAlD
Tretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.000279	0.0284	CbGpPWpGaD
Tretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.000279	0.0284	CbGpPWpGaD
Tretinoin—RARG—lymph node—skin cancer	0.000273	0.00626	CbGeAlD
Tretinoin—RARA—lymph node—skin cancer	0.000257	0.00589	CbGeAlD
Tretinoin—RXRG—Adipogenesis—PLIN2—skin cancer	0.000224	0.0228	CbGpPWpGaD
Tretinoin—CYP1A1—epithelium—skin cancer	0.000216	0.00495	CbGeAlD
Tretinoin—RARA—Adipogenesis—PLIN2—skin cancer	0.00021	0.0214	CbGpPWpGaD
Tretinoin—CYP1A1—skin of body—skin cancer	0.000205	0.00471	CbGeAlD
Tretinoin—CYP2B6—skin of body—skin cancer	0.0002	0.00458	CbGeAlD
Tretinoin—CYP2A6—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000199	0.0203	CbGpPWpGaD
Tretinoin—CYP1A1—mammalian vulva—skin cancer	0.000187	0.0043	CbGeAlD
Tretinoin—RXRA—Adipogenesis—ASIP—skin cancer	0.000181	0.0184	CbGpPWpGaD
Tretinoin—CYP2C8—female reproductive system—skin cancer	0.000174	0.00399	CbGeAlD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000171	0.0174	CbGpPWpGaD
Tretinoin—CYP2B6—lymphoid tissue—skin cancer	0.000162	0.00371	CbGeAlD
Tretinoin—CYP1A1—female reproductive system—skin cancer	0.00016	0.00368	CbGeAlD
Tretinoin—CYP4A11—PPARA activates gene expression—PLIN2—skin cancer	0.000158	0.0161	CbGpPWpGaD
Tretinoin—CYP2C18—FOXA1 transcription factor network—SHH—skin cancer	0.000157	0.016	CbGpPWpGaD
Tretinoin—CYP2B6—female reproductive system—skin cancer	0.000156	0.00358	CbGeAlD
Tretinoin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	0.000155	0.0158	CbGpPWpGaD
Tretinoin—CYP2C9—female reproductive system—skin cancer	0.000154	0.00354	CbGeAlD
Tretinoin—CYP1A1—head—skin cancer	0.000134	0.00307	CbGeAlD
Tretinoin—CYP4A11—PPAR Alpha Pathway—CDK4—skin cancer	0.000134	0.0136	CbGpPWpGaD
Tretinoin—CYP2B6—head—skin cancer	0.00013	0.00299	CbGeAlD
Tretinoin—RXRA—PPARA activates gene expression—PLIN2—skin cancer	0.000125	0.0128	CbGpPWpGaD
Tretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	0.000123	0.0125	CbGpPWpGaD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.000122	0.0125	CbGpPWpGaD
Tretinoin—CYP3A4—female reproductive system—skin cancer	0.000118	0.0027	CbGeAlD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000111	0.0113	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000111	0.0113	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—PLIN2—skin cancer	0.00011	0.0112	CbGpPWpGaD
Tretinoin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.000106	0.0109	CbGpPWpGaD
Tretinoin—RXRA—PPAR Alpha Pathway—CDK4—skin cancer	0.000106	0.0108	CbGpPWpGaD
Tretinoin—CYP1A1—lymph node—skin cancer	9.39e-05	0.00215	CbGeAlD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	8.83e-05	0.009	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	8.47e-05	0.00863	CbGpPWpGaD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	8.45e-05	0.00861	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	8.37e-05	0.00853	CbGpPWpGaD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	8.19e-05	0.00835	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	8.03e-05	0.00818	CbGpPWpGaD
Tretinoin—Angiopathy—Temozolomide—skin cancer	7.88e-05	0.000607	CcSEcCtD
Tretinoin—Cough—Bleomycin—skin cancer	7.82e-05	0.000602	CcSEcCtD
Tretinoin—Chills—Temozolomide—skin cancer	7.79e-05	0.0006	CcSEcCtD
Tretinoin—Dehydration—Docetaxel—skin cancer	7.76e-05	0.000598	CcSEcCtD
Tretinoin—Ill-defined disorder—Dactinomycin—skin cancer	7.75e-05	0.000597	CcSEcCtD
Tretinoin—Anaemia—Dactinomycin—skin cancer	7.72e-05	0.000595	CcSEcCtD
Tretinoin—Vomiting—Vemurafenib—skin cancer	7.67e-05	0.000591	CcSEcCtD
Tretinoin—Alopecia—Temozolomide—skin cancer	7.67e-05	0.000591	CcSEcCtD
Tretinoin—Dry skin—Docetaxel—skin cancer	7.65e-05	0.00059	CcSEcCtD
Tretinoin—Myalgia—Bleomycin—skin cancer	7.63e-05	0.000588	CcSEcCtD
Tretinoin—Chest pain—Bleomycin—skin cancer	7.63e-05	0.000588	CcSEcCtD
Tretinoin—Rash—Vemurafenib—skin cancer	7.61e-05	0.000586	CcSEcCtD
Tretinoin—Mental disorder—Temozolomide—skin cancer	7.61e-05	0.000586	CcSEcCtD
Tretinoin—Dermatitis—Vemurafenib—skin cancer	7.6e-05	0.000586	CcSEcCtD
Tretinoin—Hypersensitivity—Imiquimod—skin cancer	7.58e-05	0.000584	CcSEcCtD
Tretinoin—Headache—Vemurafenib—skin cancer	7.56e-05	0.000583	CcSEcCtD
Tretinoin—Erythema—Temozolomide—skin cancer	7.56e-05	0.000582	CcSEcCtD
Tretinoin—Malnutrition—Temozolomide—skin cancer	7.56e-05	0.000582	CcSEcCtD
Tretinoin—Discomfort—Bleomycin—skin cancer	7.54e-05	0.000581	CcSEcCtD
Tretinoin—Malaise—Dactinomycin—skin cancer	7.54e-05	0.000581	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Docetaxel—skin cancer	7.52e-05	0.000579	CcSEcCtD
Tretinoin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—skin cancer	7.5e-05	0.00765	CbGpPWpGaD
Tretinoin—Nasopharyngitis—Docetaxel—skin cancer	7.46e-05	0.000575	CcSEcCtD
Tretinoin—Asthenia—Imiquimod—skin cancer	7.38e-05	0.000569	CcSEcCtD
Tretinoin—Confusional state—Bleomycin—skin cancer	7.37e-05	0.000568	CcSEcCtD
Tretinoin—Anaphylactic shock—Bleomycin—skin cancer	7.31e-05	0.000563	CcSEcCtD
Tretinoin—Oedema—Bleomycin—skin cancer	7.31e-05	0.000563	CcSEcCtD
Tretinoin—Back pain—Temozolomide—skin cancer	7.31e-05	0.000563	CcSEcCtD
Tretinoin—Pruritus—Imiquimod—skin cancer	7.28e-05	0.000561	CcSEcCtD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	7.28e-05	0.00742	CbGpPWpGaD
Tretinoin—Infection—Bleomycin—skin cancer	7.26e-05	0.00056	CcSEcCtD
Tretinoin—Dysphagia—Docetaxel—skin cancer	7.21e-05	0.000556	CcSEcCtD
Tretinoin—Nausea—Vemurafenib—skin cancer	7.17e-05	0.000552	CcSEcCtD
Tretinoin—Thrombocytopenia—Bleomycin—skin cancer	7.16e-05	0.000552	CcSEcCtD
Tretinoin—Arrhythmia—Fluorouracil—skin cancer	7.15e-05	0.000551	CcSEcCtD
Tretinoin—Vision blurred—Temozolomide—skin cancer	7.12e-05	0.000549	CcSEcCtD
Tretinoin—Myalgia—Dactinomycin—skin cancer	7.11e-05	0.000548	CcSEcCtD
Tretinoin—Bronchospasm—Docetaxel—skin cancer	7.1e-05	0.000547	CcSEcCtD
Tretinoin—Tremor—Temozolomide—skin cancer	7.08e-05	0.000546	CcSEcCtD
Tretinoin—Alopecia—Fluorouracil—skin cancer	7.07e-05	0.000545	CcSEcCtD
Tretinoin—Diarrhoea—Imiquimod—skin cancer	7.04e-05	0.000543	CcSEcCtD
Tretinoin—Discomfort—Dactinomycin—skin cancer	7.03e-05	0.000542	CcSEcCtD
Tretinoin—CYP2A6—Fluoropyrimidine Activity—ERCC2—skin cancer	7.01e-05	0.00715	CbGpPWpGaD
Tretinoin—Ill-defined disorder—Temozolomide—skin cancer	7.01e-05	0.00054	CcSEcCtD
Tretinoin—Anaemia—Temozolomide—skin cancer	6.99e-05	0.000538	CcSEcCtD
Tretinoin—Anorexia—Bleomycin—skin cancer	6.97e-05	0.000537	CcSEcCtD
Tretinoin—Erythema—Fluorouracil—skin cancer	6.96e-05	0.000537	CcSEcCtD
Tretinoin—Agitation—Temozolomide—skin cancer	6.95e-05	0.000535	CcSEcCtD
Tretinoin—Hypotension—Bleomycin—skin cancer	6.83e-05	0.000527	CcSEcCtD
Tretinoin—Oedema—Dactinomycin—skin cancer	6.82e-05	0.000526	CcSEcCtD
Tretinoin—Malaise—Temozolomide—skin cancer	6.82e-05	0.000525	CcSEcCtD
Tretinoin—Dizziness—Imiquimod—skin cancer	6.81e-05	0.000525	CcSEcCtD
Tretinoin—Infection—Dactinomycin—skin cancer	6.78e-05	0.000522	CcSEcCtD
Tretinoin—Neutropenia—Docetaxel—skin cancer	6.75e-05	0.00052	CcSEcCtD
Tretinoin—Palpitations—Temozolomide—skin cancer	6.68e-05	0.000515	CcSEcCtD
Tretinoin—Thrombocytopenia—Dactinomycin—skin cancer	6.68e-05	0.000515	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Bleomycin—skin cancer	6.66e-05	0.000513	CcSEcCtD
Tretinoin—Cough—Temozolomide—skin cancer	6.6e-05	0.000508	CcSEcCtD
Tretinoin—Paraesthesia—Bleomycin—skin cancer	6.57e-05	0.000506	CcSEcCtD
Tretinoin—Weight increased—Docetaxel—skin cancer	6.56e-05	0.000506	CcSEcCtD
Tretinoin—Vision blurred—Fluorouracil—skin cancer	6.56e-05	0.000506	CcSEcCtD
Tretinoin—Convulsion—Temozolomide—skin cancer	6.55e-05	0.000505	CcSEcCtD
Tretinoin—Vomiting—Imiquimod—skin cancer	6.54e-05	0.000504	CcSEcCtD
Tretinoin—Weight decreased—Docetaxel—skin cancer	6.53e-05	0.000503	CcSEcCtD
Tretinoin—Hypertension—Temozolomide—skin cancer	6.53e-05	0.000503	CcSEcCtD
Tretinoin—Dyspnoea—Bleomycin—skin cancer	6.52e-05	0.000502	CcSEcCtD
Tretinoin—Anorexia—Dactinomycin—skin cancer	6.5e-05	0.000501	CcSEcCtD
Tretinoin—Rash—Imiquimod—skin cancer	6.49e-05	0.0005	CcSEcCtD
Tretinoin—Dermatitis—Imiquimod—skin cancer	6.48e-05	0.0005	CcSEcCtD
Tretinoin—Pneumonia—Docetaxel—skin cancer	6.47e-05	0.000499	CcSEcCtD
Tretinoin—Headache—Imiquimod—skin cancer	6.45e-05	0.000497	CcSEcCtD
Tretinoin—Anaemia—Fluorouracil—skin cancer	6.44e-05	0.000496	CcSEcCtD
Tretinoin—Arthralgia—Temozolomide—skin cancer	6.43e-05	0.000496	CcSEcCtD
Tretinoin—Myalgia—Temozolomide—skin cancer	6.43e-05	0.000496	CcSEcCtD
Tretinoin—Infestation NOS—Docetaxel—skin cancer	6.43e-05	0.000496	CcSEcCtD
Tretinoin—Infestation—Docetaxel—skin cancer	6.43e-05	0.000496	CcSEcCtD
Tretinoin—Anxiety—Temozolomide—skin cancer	6.41e-05	0.000494	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	6.39e-05	0.000492	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Docetaxel—skin cancer	6.38e-05	0.000491	CcSEcCtD
Tretinoin—Discomfort—Temozolomide—skin cancer	6.36e-05	0.00049	CcSEcCtD
Tretinoin—Decreased appetite—Bleomycin—skin cancer	6.36e-05	0.00049	CcSEcCtD
Tretinoin—Acute coronary syndrome—Docetaxel—skin cancer	6.34e-05	0.000489	CcSEcCtD
Tretinoin—Renal failure—Docetaxel—skin cancer	6.32e-05	0.000487	CcSEcCtD
Tretinoin—Neuropathy peripheral—Docetaxel—skin cancer	6.3e-05	0.000486	CcSEcCtD
Tretinoin—Myocardial infarction—Docetaxel—skin cancer	6.3e-05	0.000486	CcSEcCtD
Tretinoin—Dry mouth—Temozolomide—skin cancer	6.29e-05	0.000485	CcSEcCtD
Tretinoin—Stomatitis—Docetaxel—skin cancer	6.27e-05	0.000483	CcSEcCtD
Tretinoin—CYP1A1—PPARA activates gene expression—PLIN2—skin cancer	6.27e-05	0.00639	CbGpPWpGaD
Tretinoin—Pain—Bleomycin—skin cancer	6.25e-05	0.000482	CcSEcCtD
Tretinoin—Conjunctivitis—Docetaxel—skin cancer	6.25e-05	0.000482	CcSEcCtD
Tretinoin—Confusional state—Temozolomide—skin cancer	6.22e-05	0.000479	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Dactinomycin—skin cancer	6.21e-05	0.000479	CcSEcCtD
Tretinoin—Oedema—Temozolomide—skin cancer	6.17e-05	0.000475	CcSEcCtD
Tretinoin—Anaphylactic shock—Temozolomide—skin cancer	6.17e-05	0.000475	CcSEcCtD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	6.13e-05	0.00625	CbGpPWpGaD
Tretinoin—Infection—Temozolomide—skin cancer	6.13e-05	0.000472	CcSEcCtD
Tretinoin—Nausea—Imiquimod—skin cancer	6.11e-05	0.000471	CcSEcCtD
Tretinoin—Epistaxis—Docetaxel—skin cancer	6.07e-05	0.000467	CcSEcCtD
Tretinoin—Nervous system disorder—Temozolomide—skin cancer	6.05e-05	0.000466	CcSEcCtD
Tretinoin—Thrombocytopenia—Temozolomide—skin cancer	6.04e-05	0.000465	CcSEcCtD
Tretinoin—Convulsion—Fluorouracil—skin cancer	6.03e-05	0.000465	CcSEcCtD
Tretinoin—Feeling abnormal—Bleomycin—skin cancer	6.03e-05	0.000464	CcSEcCtD
Tretinoin—Agranulocytosis—Docetaxel—skin cancer	6e-05	0.000463	CcSEcCtD
Tretinoin—Skin disorder—Temozolomide—skin cancer	5.99e-05	0.000462	CcSEcCtD
Tretinoin—Hyperhidrosis—Temozolomide—skin cancer	5.96e-05	0.00046	CcSEcCtD
Tretinoin—Chest pain—Fluorouracil—skin cancer	5.93e-05	0.000457	CcSEcCtD
Tretinoin—Myalgia—Fluorouracil—skin cancer	5.93e-05	0.000457	CcSEcCtD
Tretinoin—Decreased appetite—Dactinomycin—skin cancer	5.93e-05	0.000457	CcSEcCtD
Tretinoin—Fatigue—Dactinomycin—skin cancer	5.88e-05	0.000453	CcSEcCtD
Tretinoin—Anorexia—Temozolomide—skin cancer	5.88e-05	0.000453	CcSEcCtD
Tretinoin—Discomfort—Fluorouracil—skin cancer	5.86e-05	0.000451	CcSEcCtD
Tretinoin—Pain—Dactinomycin—skin cancer	5.83e-05	0.000449	CcSEcCtD
Tretinoin—Urticaria—Bleomycin—skin cancer	5.81e-05	0.000448	CcSEcCtD
Tretinoin—Haemoglobin—Docetaxel—skin cancer	5.8e-05	0.000447	CcSEcCtD
Tretinoin—Body temperature increased—Bleomycin—skin cancer	5.78e-05	0.000445	CcSEcCtD
Tretinoin—Haemorrhage—Docetaxel—skin cancer	5.77e-05	0.000445	CcSEcCtD
Tretinoin—Hepatitis—Docetaxel—skin cancer	5.77e-05	0.000445	CcSEcCtD
Tretinoin—Hypoaesthesia—Docetaxel—skin cancer	5.74e-05	0.000443	CcSEcCtD
Tretinoin—Confusional state—Fluorouracil—skin cancer	5.73e-05	0.000442	CcSEcCtD
Tretinoin—Pharyngitis—Docetaxel—skin cancer	5.73e-05	0.000442	CcSEcCtD
Tretinoin—Urinary tract disorder—Docetaxel—skin cancer	5.7e-05	0.000439	CcSEcCtD
Tretinoin—Oedema peripheral—Docetaxel—skin cancer	5.69e-05	0.000438	CcSEcCtD
Tretinoin—Oedema—Fluorouracil—skin cancer	5.68e-05	0.000438	CcSEcCtD
Tretinoin—Anaphylactic shock—Fluorouracil—skin cancer	5.68e-05	0.000438	CcSEcCtD
Tretinoin—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—skin cancer	5.68e-05	0.00578	CbGpPWpGaD
Tretinoin—CYP4A11—Arachidonic acid metabolism—PTGS2—skin cancer	5.66e-05	0.00577	CbGpPWpGaD
Tretinoin—Urethral disorder—Docetaxel—skin cancer	5.66e-05	0.000436	CcSEcCtD
Tretinoin—Infection—Fluorouracil—skin cancer	5.65e-05	0.000435	CcSEcCtD
Tretinoin—Feeling abnormal—Dactinomycin—skin cancer	5.62e-05	0.000433	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Temozolomide—skin cancer	5.62e-05	0.000433	CcSEcCtD
Tretinoin—Insomnia—Temozolomide—skin cancer	5.58e-05	0.00043	CcSEcCtD
Tretinoin—Gastrointestinal pain—Dactinomycin—skin cancer	5.58e-05	0.00043	CcSEcCtD
Tretinoin—Nervous system disorder—Fluorouracil—skin cancer	5.57e-05	0.000429	CcSEcCtD
Tretinoin—Thrombocytopenia—Fluorouracil—skin cancer	5.56e-05	0.000429	CcSEcCtD
Tretinoin—Visual impairment—Docetaxel—skin cancer	5.56e-05	0.000429	CcSEcCtD
Tretinoin—Tachycardia—Fluorouracil—skin cancer	5.55e-05	0.000427	CcSEcCtD
Tretinoin—Paraesthesia—Temozolomide—skin cancer	5.54e-05	0.000427	CcSEcCtD
Tretinoin—Dyspnoea—Temozolomide—skin cancer	5.5e-05	0.000424	CcSEcCtD
Tretinoin—Somnolence—Temozolomide—skin cancer	5.48e-05	0.000423	CcSEcCtD
Tretinoin—Erythema multiforme—Docetaxel—skin cancer	5.46e-05	0.000421	CcSEcCtD
Tretinoin—Dyspepsia—Temozolomide—skin cancer	5.43e-05	0.000418	CcSEcCtD
Tretinoin—Anorexia—Fluorouracil—skin cancer	5.42e-05	0.000417	CcSEcCtD
Tretinoin—Eye disorder—Docetaxel—skin cancer	5.4e-05	0.000416	CcSEcCtD
Tretinoin—Body temperature increased—Dactinomycin—skin cancer	5.39e-05	0.000415	CcSEcCtD
Tretinoin—Abdominal pain—Dactinomycin—skin cancer	5.39e-05	0.000415	CcSEcCtD
Tretinoin—Hypersensitivity—Bleomycin—skin cancer	5.39e-05	0.000415	CcSEcCtD
Tretinoin—Decreased appetite—Temozolomide—skin cancer	5.36e-05	0.000413	CcSEcCtD
Tretinoin—Flushing—Docetaxel—skin cancer	5.36e-05	0.000413	CcSEcCtD
Tretinoin—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—skin cancer	5.34e-05	0.00544	CbGpPWpGaD
Tretinoin—Gastrointestinal disorder—Temozolomide—skin cancer	5.33e-05	0.00041	CcSEcCtD
Tretinoin—Fatigue—Temozolomide—skin cancer	5.32e-05	0.00041	CcSEcCtD
Tretinoin—Hypotension—Fluorouracil—skin cancer	5.31e-05	0.000409	CcSEcCtD
Tretinoin—Pain—Temozolomide—skin cancer	5.27e-05	0.000406	CcSEcCtD
Tretinoin—Constipation—Temozolomide—skin cancer	5.27e-05	0.000406	CcSEcCtD
Tretinoin—Asthenia—Bleomycin—skin cancer	5.25e-05	0.000404	CcSEcCtD
Tretinoin—Angiopathy—Docetaxel—skin cancer	5.24e-05	0.000404	CcSEcCtD
Tretinoin—Chills—Docetaxel—skin cancer	5.18e-05	0.000399	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Fluorouracil—skin cancer	5.18e-05	0.000399	CcSEcCtD
Tretinoin—Pruritus—Bleomycin—skin cancer	5.17e-05	0.000399	CcSEcCtD
Tretinoin—Arrhythmia—Docetaxel—skin cancer	5.16e-05	0.000397	CcSEcCtD
Tretinoin—Insomnia—Fluorouracil—skin cancer	5.14e-05	0.000396	CcSEcCtD
Tretinoin—Paraesthesia—Fluorouracil—skin cancer	5.1e-05	0.000393	CcSEcCtD
Tretinoin—Alopecia—Docetaxel—skin cancer	5.1e-05	0.000393	CcSEcCtD
Tretinoin—Feeling abnormal—Temozolomide—skin cancer	5.08e-05	0.000392	CcSEcCtD
Tretinoin—Dyspnoea—Fluorouracil—skin cancer	5.07e-05	0.00039	CcSEcCtD
Tretinoin—Mental disorder—Docetaxel—skin cancer	5.06e-05	0.00039	CcSEcCtD
Tretinoin—Somnolence—Fluorouracil—skin cancer	5.05e-05	0.000389	CcSEcCtD
Tretinoin—Gastrointestinal pain—Temozolomide—skin cancer	5.04e-05	0.000389	CcSEcCtD
Tretinoin—Erythema—Docetaxel—skin cancer	5.03e-05	0.000387	CcSEcCtD
Tretinoin—Malnutrition—Docetaxel—skin cancer	5.03e-05	0.000387	CcSEcCtD
Tretinoin—Hypersensitivity—Dactinomycin—skin cancer	5.02e-05	0.000387	CcSEcCtD
Tretinoin—Dyspepsia—Fluorouracil—skin cancer	5e-05	0.000386	CcSEcCtD
Tretinoin—ALDH1A1—Metabolism—PLIN2—skin cancer	4.95e-05	0.00504	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PLIN2—skin cancer	4.95e-05	0.00504	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PLIN2—skin cancer	4.95e-05	0.00504	CbGpPWpGaD
Tretinoin—Decreased appetite—Fluorouracil—skin cancer	4.94e-05	0.000381	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Fluorouracil—skin cancer	4.91e-05	0.000378	CcSEcCtD
Tretinoin—Urticaria—Temozolomide—skin cancer	4.9e-05	0.000378	CcSEcCtD
Tretinoin—Asthenia—Dactinomycin—skin cancer	4.89e-05	0.000377	CcSEcCtD
Tretinoin—Abdominal pain—Temozolomide—skin cancer	4.88e-05	0.000376	CcSEcCtD
Tretinoin—Body temperature increased—Temozolomide—skin cancer	4.88e-05	0.000376	CcSEcCtD
Tretinoin—Back pain—Docetaxel—skin cancer	4.86e-05	0.000375	CcSEcCtD
Tretinoin—Pain—Fluorouracil—skin cancer	4.86e-05	0.000375	CcSEcCtD
Tretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—skin cancer	4.72e-05	0.00481	CbGpPWpGaD
Tretinoin—Feeling abnormal—Fluorouracil—skin cancer	4.68e-05	0.000361	CcSEcCtD
Tretinoin—Diarrhoea—Dactinomycin—skin cancer	4.67e-05	0.00036	CcSEcCtD
Tretinoin—Vomiting—Bleomycin—skin cancer	4.65e-05	0.000358	CcSEcCtD
Tretinoin—Anaemia—Docetaxel—skin cancer	4.65e-05	0.000358	CcSEcCtD
Tretinoin—Rash—Bleomycin—skin cancer	4.61e-05	0.000355	CcSEcCtD
Tretinoin—Dermatitis—Bleomycin—skin cancer	4.61e-05	0.000355	CcSEcCtD
Tretinoin—Hypersensitivity—Temozolomide—skin cancer	4.54e-05	0.00035	CcSEcCtD
Tretinoin—Urticaria—Fluorouracil—skin cancer	4.51e-05	0.000348	CcSEcCtD
Tretinoin—Syncope—Docetaxel—skin cancer	4.51e-05	0.000347	CcSEcCtD
Tretinoin—Body temperature increased—Fluorouracil—skin cancer	4.49e-05	0.000346	CcSEcCtD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—CDK4—skin cancer	4.45e-05	0.00453	CbGpPWpGaD
Tretinoin—Palpitations—Docetaxel—skin cancer	4.44e-05	0.000342	CcSEcCtD
Tretinoin—Asthenia—Temozolomide—skin cancer	4.43e-05	0.000341	CcSEcCtD
Tretinoin—Loss of consciousness—Docetaxel—skin cancer	4.42e-05	0.00034	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	4.41e-05	0.0045	CbGpPWpGaD
Tretinoin—Cough—Docetaxel—skin cancer	4.39e-05	0.000338	CcSEcCtD
Tretinoin—Pruritus—Temozolomide—skin cancer	4.36e-05	0.000336	CcSEcCtD
Tretinoin—Convulsion—Docetaxel—skin cancer	4.35e-05	0.000336	CcSEcCtD
Tretinoin—Nausea—Bleomycin—skin cancer	4.34e-05	0.000335	CcSEcCtD
Tretinoin—Hypertension—Docetaxel—skin cancer	4.34e-05	0.000334	CcSEcCtD
Tretinoin—Vomiting—Dactinomycin—skin cancer	4.34e-05	0.000334	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	4.3e-05	0.00439	CbGpPWpGaD
Tretinoin—Rash—Dactinomycin—skin cancer	4.3e-05	0.000331	CcSEcCtD
Tretinoin—Arthralgia—Docetaxel—skin cancer	4.28e-05	0.00033	CcSEcCtD
Tretinoin—Myalgia—Docetaxel—skin cancer	4.28e-05	0.00033	CcSEcCtD
Tretinoin—Chest pain—Docetaxel—skin cancer	4.28e-05	0.00033	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	4.25e-05	0.000327	CcSEcCtD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4.24e-05	0.00432	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	4.23e-05	0.00431	CbGpPWpGaD
Tretinoin—Diarrhoea—Temozolomide—skin cancer	4.22e-05	0.000325	CcSEcCtD
Tretinoin—Hypersensitivity—Fluorouracil—skin cancer	4.19e-05	0.000323	CcSEcCtD
Tretinoin—Dry mouth—Docetaxel—skin cancer	4.18e-05	0.000322	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	4.18e-05	0.00426	CbGpPWpGaD
Tretinoin—Confusional state—Docetaxel—skin cancer	4.14e-05	0.000319	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	4.13e-05	0.00421	CbGpPWpGaD
Tretinoin—Anaphylactic shock—Docetaxel—skin cancer	4.1e-05	0.000316	CcSEcCtD
Tretinoin—Oedema—Docetaxel—skin cancer	4.1e-05	0.000316	CcSEcCtD
Tretinoin—Dizziness—Temozolomide—skin cancer	4.08e-05	0.000314	CcSEcCtD
Tretinoin—Infection—Docetaxel—skin cancer	4.08e-05	0.000314	CcSEcCtD
Tretinoin—Nausea—Dactinomycin—skin cancer	4.05e-05	0.000312	CcSEcCtD
Tretinoin—Shock—Docetaxel—skin cancer	4.04e-05	0.000311	CcSEcCtD
Tretinoin—Nervous system disorder—Docetaxel—skin cancer	4.02e-05	0.00031	CcSEcCtD
Tretinoin—Pruritus—Fluorouracil—skin cancer	4.02e-05	0.00031	CcSEcCtD
Tretinoin—Thrombocytopenia—Docetaxel—skin cancer	4.02e-05	0.000309	CcSEcCtD
Tretinoin—Tachycardia—Docetaxel—skin cancer	4e-05	0.000309	CcSEcCtD
Tretinoin—ALDH1A1—Metabolism—CSPG4—skin cancer	3.99e-05	0.00406	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—CSPG4—skin cancer	3.99e-05	0.00406	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—CSPG4—skin cancer	3.99e-05	0.00406	CbGpPWpGaD
Tretinoin—Skin disorder—Docetaxel—skin cancer	3.98e-05	0.000307	CcSEcCtD
Tretinoin—Vomiting—Temozolomide—skin cancer	3.92e-05	0.000302	CcSEcCtD
Tretinoin—Anorexia—Docetaxel—skin cancer	3.91e-05	0.000301	CcSEcCtD
Tretinoin—Rash—Temozolomide—skin cancer	3.89e-05	0.0003	CcSEcCtD
Tretinoin—Diarrhoea—Fluorouracil—skin cancer	3.89e-05	0.0003	CcSEcCtD
Tretinoin—Dermatitis—Temozolomide—skin cancer	3.89e-05	0.000299	CcSEcCtD
Tretinoin—Headache—Temozolomide—skin cancer	3.86e-05	0.000298	CcSEcCtD
Tretinoin—Hypotension—Docetaxel—skin cancer	3.83e-05	0.000295	CcSEcCtD
Tretinoin—Dizziness—Fluorouracil—skin cancer	3.76e-05	0.00029	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Docetaxel—skin cancer	3.74e-05	0.000288	CcSEcCtD
Tretinoin—Insomnia—Docetaxel—skin cancer	3.71e-05	0.000286	CcSEcCtD
Tretinoin—Paraesthesia—Docetaxel—skin cancer	3.68e-05	0.000284	CcSEcCtD
Tretinoin—Nausea—Temozolomide—skin cancer	3.66e-05	0.000282	CcSEcCtD
Tretinoin—Dyspnoea—Docetaxel—skin cancer	3.66e-05	0.000282	CcSEcCtD
Tretinoin—Somnolence—Docetaxel—skin cancer	3.65e-05	0.000281	CcSEcCtD
Tretinoin—Vomiting—Fluorouracil—skin cancer	3.61e-05	0.000278	CcSEcCtD
Tretinoin—Dyspepsia—Docetaxel—skin cancer	3.61e-05	0.000278	CcSEcCtD
Tretinoin—Rash—Fluorouracil—skin cancer	3.58e-05	0.000276	CcSEcCtD
Tretinoin—Dermatitis—Fluorouracil—skin cancer	3.58e-05	0.000276	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—SCN10A—skin cancer	3.57e-05	0.00364	CbGpPWpGaD
Tretinoin—Decreased appetite—Docetaxel—skin cancer	3.57e-05	0.000275	CcSEcCtD
Tretinoin—Headache—Fluorouracil—skin cancer	3.56e-05	0.000274	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Docetaxel—skin cancer	3.54e-05	0.000273	CcSEcCtD
Tretinoin—Fatigue—Docetaxel—skin cancer	3.54e-05	0.000273	CcSEcCtD
Tretinoin—Constipation—Docetaxel—skin cancer	3.51e-05	0.00027	CcSEcCtD
Tretinoin—Pain—Docetaxel—skin cancer	3.51e-05	0.00027	CcSEcCtD
Tretinoin—Feeling abnormal—Docetaxel—skin cancer	3.38e-05	0.00026	CcSEcCtD
Tretinoin—Nausea—Fluorouracil—skin cancer	3.38e-05	0.00026	CcSEcCtD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.36e-05	0.00343	CbGpPWpGaD
Tretinoin—Gastrointestinal pain—Docetaxel—skin cancer	3.35e-05	0.000258	CcSEcCtD
Tretinoin—Abdominal pain—Docetaxel—skin cancer	3.24e-05	0.00025	CcSEcCtD
Tretinoin—Body temperature increased—Docetaxel—skin cancer	3.24e-05	0.00025	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	3.08e-05	0.00314	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.03e-05	0.00309	CbGpPWpGaD
Tretinoin—Hypersensitivity—Docetaxel—skin cancer	3.02e-05	0.000233	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	2.95e-05	0.00301	CbGpPWpGaD
Tretinoin—Asthenia—Docetaxel—skin cancer	2.94e-05	0.000227	CcSEcCtD
Tretinoin—Pruritus—Docetaxel—skin cancer	2.9e-05	0.000224	CcSEcCtD
Tretinoin—Diarrhoea—Docetaxel—skin cancer	2.81e-05	0.000216	CcSEcCtD
Tretinoin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—skin cancer	2.78e-05	0.00283	CbGpPWpGaD
Tretinoin—Dizziness—Docetaxel—skin cancer	2.71e-05	0.000209	CcSEcCtD
Tretinoin—CRABP1—Metabolism—ENO2—skin cancer	2.71e-05	0.00276	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—ENO2—skin cancer	2.71e-05	0.00276	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—ENO2—skin cancer	2.71e-05	0.00276	CbGpPWpGaD
Tretinoin—Vomiting—Docetaxel—skin cancer	2.61e-05	0.000201	CcSEcCtD
Tretinoin—Rash—Docetaxel—skin cancer	2.59e-05	0.000199	CcSEcCtD
Tretinoin—Dermatitis—Docetaxel—skin cancer	2.58e-05	0.000199	CcSEcCtD
Tretinoin—Headache—Docetaxel—skin cancer	2.57e-05	0.000198	CcSEcCtD
Tretinoin—CYP2A6—Fluoropyrimidine Activity—TP53—skin cancer	2.5e-05	0.00255	CbGpPWpGaD
Tretinoin—Nausea—Docetaxel—skin cancer	2.44e-05	0.000188	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	2.4e-05	0.00245	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—IL6—skin cancer	2.32e-05	0.00237	CbGpPWpGaD
Tretinoin—CYP1A1—Arachidonic acid metabolism—PTGS2—skin cancer	2.25e-05	0.00229	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—IL6—skin cancer	2.19e-05	0.00223	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	2.15e-05	0.00219	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.12e-05	0.00216	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.12e-05	0.00216	CbGpPWpGaD
Tretinoin—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	2.06e-05	0.0021	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	2.06e-05	0.0021	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—RASA1—skin cancer	2.05e-05	0.00209	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.97e-05	0.00201	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PLIN2—skin cancer	1.89e-05	0.00192	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	1.87e-05	0.0019	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.83e-05	0.00187	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.76e-05	0.00179	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—ERCC2—skin cancer	1.7e-05	0.00173	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.68e-05	0.00172	CbGpPWpGaD
Tretinoin—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	1.68e-05	0.00171	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PLIN2—skin cancer	1.65e-05	0.00168	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	1.61e-05	0.00164	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—ERCC2—skin cancer	1.57e-05	0.0016	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—ERCC2—skin cancer	1.57e-05	0.0016	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—ERCC2—skin cancer	1.57e-05	0.0016	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.54e-05	0.00157	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.54e-05	0.00157	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CSPG4—skin cancer	1.52e-05	0.00155	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PLIN2—skin cancer	1.5e-05	0.00153	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—ERCC2—skin cancer	1.37e-05	0.00139	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.37e-05	0.00139	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CSPG4—skin cancer	1.33e-05	0.00136	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.26e-05	0.00128	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—ERCC2—skin cancer	1.25e-05	0.00128	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—ERCC2—skin cancer	1.23e-05	0.00125	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CSPG4—skin cancer	1.21e-05	0.00123	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—ERCC2—skin cancer	1.18e-05	0.0012	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—ERCC2—skin cancer	1.18e-05	0.0012	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—IL6—skin cancer	1.14e-05	0.00116	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PLIN2—skin cancer	1.1e-05	0.00112	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ENO2—skin cancer	1.03e-05	0.00105	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.03e-05	0.00105	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PLIN2—skin cancer	1.01e-05	0.00103	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—CDK4—skin cancer	1.01e-05	0.00102	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PTGS2—skin cancer	9.44e-06	0.000962	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PTGS2—skin cancer	9.44e-06	0.000962	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PTGS2—skin cancer	9.44e-06	0.000962	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	9.15e-06	0.000932	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ENO2—skin cancer	9.04e-06	0.000922	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CSPG4—skin cancer	8.85e-06	0.000902	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ENO2—skin cancer	8.21e-06	0.000836	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PLIN2—skin cancer	8.12e-06	0.000827	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CSPG4—skin cancer	8.11e-06	0.000826	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.09e-06	0.000825	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PLIN2—skin cancer	7.93e-06	0.000809	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PLIN2—skin cancer	7.49e-06	0.000764	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PLIN2—skin cancer	6.87e-06	0.0007	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CSPG4—skin cancer	6.54e-06	0.000667	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.42e-06	0.000654	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CSPG4—skin cancer	6.39e-06	0.000652	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—ERCC2—skin cancer	6.13e-06	0.000625	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CSPG4—skin cancer	6.04e-06	0.000616	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ENO2—skin cancer	6.01e-06	0.000613	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ERCC2—skin cancer	6.01e-06	0.000613	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PLIN2—skin cancer	5.59e-06	0.00057	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—NRAS—skin cancer	5.59e-06	0.00057	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CSPG4—skin cancer	5.54e-06	0.000564	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ENO2—skin cancer	5.51e-06	0.000562	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ERCC2—skin cancer	5.25e-06	0.000535	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—KRAS—skin cancer	4.81e-06	0.000491	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ERCC2—skin cancer	4.77e-06	0.000486	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CSPG4—skin cancer	4.51e-06	0.000459	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ENO2—skin cancer	4.45e-06	0.000453	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ENO2—skin cancer	4.35e-06	0.000443	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ENO2—skin cancer	4.11e-06	0.000419	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—HRAS—skin cancer	4.09e-06	0.000417	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—IL6—skin cancer	3.92e-06	0.000399	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ENO2—skin cancer	3.76e-06	0.000384	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PLIN2—skin cancer	3.69e-06	0.000376	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTGS2—skin cancer	3.6e-06	0.000367	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ERCC2—skin cancer	3.49e-06	0.000356	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.21e-06	0.000327	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ERCC2—skin cancer	3.2e-06	0.000326	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—skin cancer	3.15e-06	0.000321	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ENO2—skin cancer	3.06e-06	0.000312	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CSPG4—skin cancer	2.97e-06	0.000303	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.94e-06	0.0003	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—skin cancer	2.86e-06	0.000291	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ERCC2—skin cancer	2.58e-06	0.000263	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ERCC2—skin cancer	2.52e-06	0.000257	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.4e-06	0.000244	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ERCC2—skin cancer	2.39e-06	0.000243	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ERCC2—skin cancer	2.19e-06	0.000223	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—skin cancer	2.09e-06	0.000213	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ENO2—skin cancer	2.02e-06	0.000206	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—skin cancer	1.92e-06	0.000196	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ERCC2—skin cancer	1.78e-06	0.000181	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—skin cancer	1.55e-06	0.000158	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—skin cancer	1.51e-06	0.000154	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—skin cancer	1.43e-06	0.000146	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—skin cancer	1.31e-06	0.000134	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ERCC2—skin cancer	1.17e-06	0.00012	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—skin cancer	1.07e-06	0.000109	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—skin cancer	7.04e-07	7.17e-05	CbGpPWpGaD
